What does the future look like with the curren... - CLL Support
What does the future look like with the current BTK & BCL-2 inhibitors?
You need to be a member of this community to see this post.
Read more about...
9 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'
In just a short time, in many places, BTK inhibitors (BTKi) have largely replaced...
CLL survival times ARE improving, thanks to BTK and BCL-2 inhibitors
Many of us were shocked after our CLL/SLL diagnosis when we googled for survival times....
Can Venetoclax/Obinituzimab reduce the risk of additional somatic mutations? - Not necessarily. The BTK inhibitors are excellent at....
Below is a repost from CLLSLL@groups.io ( permission granted by Dr. Furman)
- I believe this...
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease
From the New England Journal of Medicine 10th December 2023
"The CLL treatment landscape has...
2 Issues: Ibrutinib side effects + Ibrutinib plus Venetoclax Treatment
Hi, dear friends,
My mom started the treatment with ibrutinib 10 days...
Related Posts
- Clinical trial results & reviews of new treatments for CLL written in easy to understand terms
- Dr. John Allan - Chronic Lymphocytic Leukemia (CLL) Patients @Undetectable Measurable Residual Disease (MRD) after Ibrutinib Plus Venetoclax
- Ibrutinib combinations in CLL therapy: scientific rationale and clinical results
Ibrutinib and Obinutuzumab with Venetoclax
Venetoclax and ibrutinib trial
